Mylan CEO to testify before Congressional committee on EpiPen price hikes

Heather Bresch, the CEO of Mylan Pharmaceuticals, will testify before the U.S. Congressional oversight committee on the cost increases for the life-saving EpiPen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.